Indications and Efficacy

The information here is based on the Summary of Product Characteristics for Ireland. Please note that registration conditions differ internationally, so for Prescribing Information, please refer to the Summary of Product Characteristics for your home country.

Download the Seroquel XR product information in pdf format.

SEROQUEL XR and SEROQUEL indications

There are a large number of clinical trials that demonstrate the efficacy of SEROQUEL XR and SEROQUEL in patients with schizophrenia and bipolar disorder, including bipolar mania, bipolar depression and the prevention of recurrence of bipolar disorder.  SEROQUEL XR and SEROQUEL efficacy data are reflected below. 

SEROQUEL XR - Indications and efficacy

SEROQUEL XR is indicated for the treatment of schizophrenia.

SEROQUEL XR is effective in preventing relapse in stable schizophrenic patients who have been maintained on SEROQUEL XR.

SEROQUEL XR is indicated for treatment of bipolar disorder.

SEROQUEL XR is indicated for the treatment of moderate to severe manic episodes in bipolar disorder.

SEROQUEL XR is indicated for the treatment of major depressive episodes in bipolar disorder.

SEROQUEL XR is indicated for the prevention of recurrence in patients with bipolar disorder, in patients whose manic or depressive episode has responded to SEROQUEL XR and SEROQUEL treatment.

Please refer to the full prescribing information for SEROQUEL XR

Please refer to the full prescribing information for SEROQUEL

For further information please use the following links:

• SEROQUEL XR efficacy in schizophrenia treatment
• SEROQUEL XR efficacy in bipolar disorder
• SEROQUEL XR efficacy in bipolar mania treatment
• SEROQUEL XR efficacy in bipolar depression
• SEROQUEL XR: prevention of recurrence in bipolar disorder

SEROQUEL IR has the same indications.

Download the Seroquel product information in pdf format.

Safety Information

Safety information is provided in a separate section please use the following link:

Safety and side effects